FLOW-CYTOMETRIC ANALYSIS OF DNA DISTRIBUTION AFTER VP16-213 TREATMENT OF LEWIS LUNG-CARCINOMA

被引：1
|
作者：
ERBA, E [1 ]
UBEZIO, P [1 ]
COLOMBO, T [1 ]
BROGGINI, M [1 ]
TORTI, L [1 ]
VAGHI, M [1 ]
DINCALCI, M [1 ]
MORASCA, L [1 ]
机构：
[1] MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：208 / 211
页数：4
相关论文
共 50 条
  • [21] FLOW-CYTOMETRIC DNA ANALYSIS OF STAGES IB AND IIA CERVICAL-CARCINOMA
    ZANETTA, GM
    KATZMANN, JA
    KEENEY, GL
    KINNEY, WK
    CHA, SS
    PODRATZ, KC
    GYNECOLOGIC ONCOLOGY, 1992, 46 (01) : 13 - 19
  • [22] INVITRO CYTO-TOXICITY OF VP-16 ON PRIMARY TUMOR AND METASTASIS OF LEWIS LUNG-CARCINOMA
    DINCALCI, M
    ERBA, E
    VAGHI, M
    MORASCA, L
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (04): : 377 - 380
  • [23] COMPARISON OF DNA BREAKAGE PRODUCED BY VP16-213 AND VM26 AND REPAIR IN SENSITIVE AND RESISTANT HUMAN-LUNG CARCINOMA CELL-LINES
    LONG, BH
    MUSIAL, ST
    BUTWELL, T
    BRATTAIN, MG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 333 - 333
  • [24] DNA FLOW-CYTOMETRIC OF EPIDERMOID LUNG-CANCER AS PROGNOSTIC FACTOR AFTER CURATIVE SURGICAL-TREATMENT
    VANBODEGOM, PC
    BAAK, JPA
    WAGENAAR, SS
    VANDERSCHUEREN, RGJRA
    PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (04) : 468 - 468
  • [25] PROLIFERATING CELL NUCLEAR ANTIGEN AND KI-67 IN LUNG-CARCINOMA - CORRELATION WITH DNA FLOW CYTOMETRIC ANALYSIS
    KAWAI, T
    SUZUKI, M
    KONO, S
    SHINOMIYA, N
    ROKUTANDA, M
    TAKAGI, K
    OGATA, T
    TAMAI, S
    CANCER, 1994, 74 (09) : 2468 - 2475
  • [26] CARBOPLATIN AND VP16-213 WITH RADIOTHERAPY (RT) AS INITIAL TREATMENT FOR PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    OLVER, IN
    RAGHAVAN, D
    BISHOP, JF
    MORSTYN, G
    KEFFORD, R
    STUARTHARRIS, R
    ARONEY, R
    BALL, D
    FOX, R
    HILLCOAT, B
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 62 - 62
  • [27] CHEMOTHERAPY COMBINATION WITH CYCLOPHOSPHAMIDE (CTX) ADRIAMYCIN (ADM), VINCRISTINE (VCR), AND VP16-213 IN SMALL CELL-CARCINOMA OF THE LUNG (SCCL)
    GRACIA, JM
    JIMENEZ, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 199 - 201
  • [28] REVERSED SENSITIVITY TO ANTICANCER DRUGS VP16-213 (ETOPOSIDE) AND MITOMYCIN-C BY HUMAN-LUNG CARCINOMA CELL-LINES
    MUSIAL, ST
    BRATTAIN, MG
    LONG, BH
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1144 - 1144
  • [29] VP-16-213 AFTER FAILURE WITH COMBINATION CHEMOTHERAPY FOR SMALL CELL-CARCINOMA OF THE LUNG
    TEMPERO, M
    FOLEY, JF
    KESSINGER, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 460 - 460
  • [30] RESISTANCE TO VP16-213 AND VM26 IS LOCALIZED TO NUCLEI OF RESISTANT HUMAN-LUNG AND COLON-CARCINOMA CELL-LINES
    LONG, BH
    MUSIAL, ST
    NEWHOUSE, LA
    BRATTAIN, MG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 348 - 348
12345